LACTATED RINGER'S IN PLASTIC CONTAINER
Clinical safety rating
cautionComprehensive clinical and safety monograph for LACTATED RINGER'S IN PLASTIC CONTAINER (LACTATED RINGER'S IN PLASTIC CONTAINER).
Lactated Ringer's solution provides isotonic crystalloid fluids that expand intravascular volume and replace fluid and electrolyte deficits. Its components (sodium, chloride, potassium, calcium, and lactate) restore extracellular fluid composition. Lactate is metabolized to bicarbonate in the liver, providing a buffer to correct metabolic acidosis.
| Metabolism | Lactate is primarily metabolized by the liver (oxidation to pyruvate and gluconeogenesis) and to a lesser extent by kidneys and heart. Bicarbonate is generated via the Cori cycle. |
| Excretion | Renal: >95% (primarily lactate metabolism to bicarbonate, but electrolytes and water are excreted renally); Biliary/Fecal: negligible. |
| Half-life | Not applicable for a solution; the infused crystalloid distributes and is eliminated with a distribution half-life of 15-30 minutes and a terminal elimination half-life of 1-2 hours for the water component. |
| Protein binding | None (lactate and electrolytes are not protein-bound; essentially 0% bound). |
| Volume of Distribution | 0.2-0.3 L/kg (confined to extracellular fluid; approximately 20-30% of body weight). |
| Bioavailability | Intravenous: 100%. |
| Onset of Action | Intravenous: Immediate (within seconds to minutes) for volume expansion and electrolyte effects. |
| Duration of Action | Intravenous: Volume effect lasts 30-60 minutes; electrolyte effects persist while infused and shortly after. |
| Molecular Weight | The molecular weight varies; Sodium lactate is 112.06 g/mol, components are small molecules. Overall solution has no single molecular weight. For drug monograph purposes, consider 112.06 for sodium lactate component. |
Intravenous infusion; typical adult dose 500-1000 mL as a single dose, rate 30-40 mL/kg/24 hours with careful monitoring of fluid and electrolyte status.
| Dosage form | SOLUTION |
| Renal impairment | Contraindicated or use with extreme caution in renal failure; avoid in severe renal impairment (eGFR <30 mL/min) due to risk of hyperkalemia and fluid overload; consider alternative fluids. |
| Liver impairment | Use with caution in hepatic impairment; no specific dose adjustment recommended, but monitor for lactic acidosis in severe hepatic dysfunction (Child-Pugh C). |
| Pediatric use | Weight-based: Initial dose 20-30 mL/kg, then maintenance 100-150 mL/kg/day for small children, adjusted based on clinical response and serum electrolyte monitoring. |
| Geriatric use | Elderly: Use with caution due to potential for fluid overload, renal impairment, and electrolyte disturbances; adjust rate and volume based on renal function and cardiac status; typical starting rate 20-30 mL/kg/24 hours. |
| 1st trimester | Lactated Ringer's solution is generally considered safe during all trimesters when used as indicated for fluid and electrolyte resuscitation. No known teratogenic effects. Use only when clearly needed. |
| 2nd trimester | Safe for use as clinically indicated. Monitor for fluid overload, which may affect pregnancy outcomes. |
| 3rd trimester | Safe for use as clinically indicated. Monitor for fluid and electrolyte balance, especially in preeclampsia or compromised renal function. |
Clinical note
Comprehensive clinical and safety monograph for LACTATED RINGER'S IN PLASTIC CONTAINER (LACTATED RINGER'S IN PLASTIC CONTAINER).
| Placental transfer | Components of Lactated Ringer's solution (water, electrolytes, lactate) freely cross the placenta, but they are normal physiologic substances and pose no known risk to the fetus when used appropriately. |
| Breastfeeding | Lactated Ringer's solution is a standard crystalloid fluid replacement and is considered compatible with breastfeeding. The components (sodium, potassium, calcium, chloride, lactate) are normal blood constituents and are not expected to cause adverse effects in nursing infants. |
| Lactation Rating | L1 (Safest) |
| Teratogenic Risk | No evidence of teratogenicity from balanced crystalloid solutions. Lactated Ringer's is isotonic and contains electrolytes and lactate at physiologic concentrations. No fetal risk identified with standard use during any trimester. Administration of large volumes may cause maternal fluid overload, electrolyte disturbances, or acid-base imbalance, which could indirectly affect fetal homeostasis. |
| Fetal Monitoring | Monitor maternal vital signs, urine output, serum electrolytes (sodium, potassium, calcium, chloride), acid-base status (pH, lactate, bicarbonate), and fluid balance. Fetal monitoring (heart rate, biophysical profile) as clinically indicated for maternal conditions requiring IV fluid therapy (e.g., preeclampsia, hyperemesis, labor). |
| Fertility Effects | No known effects on fertility or reproductive function. Lactated Ringer's is a maintenance/replacement fluid without hormonal or gametotoxic properties. |
■ FDA Black Box Warning
WARNING: Do not use for cardiopulmonary bypass or in neonates with elevated lactate levels. Contains calcium; co-administration with ceftriaxone may cause fatal precipitation. Do not administer with blood through same IV line due to risk of coagulation.
| Serious Effects |
HyperkalemiaHypercalcemiaMetabolic alkalosisLactic acidosis (do not use as it may worsen acidosis)Severe renal impairment (anuria or oliguria)Known hypersensitivity to any component
| Precautions | Monitor for fluid overload, especially in renal impairment, heart failure, or pulmonary edema. Use caution in liver disease (lactate metabolism may be impaired). Avoid in severe metabolic alkalosis. May cause hyperkalemia in renal failure due to potassium content. |
| Food/Dietary | No direct food interactions. However, patients receiving LR for volume resuscitation should maintain a balanced diet as tolerated. Avoid excessive potassium-rich foods if hyperkalemia risk. |
| Clinical Pearls | Lactated Ringer's (LR) is an isotonic crystalloid that closely mimics plasma electrolyte composition. Contraindicated in lactic acidosis due to lactate metabolism worsening acidosis. Avoid in severe liver failure (impaired lactate clearance). Use with caution in hyperkalemia (contains 4 mEq/L potassium). Compatible with blood transfusions (unlike plain Ringer's). Do not administer with alkalinizing agents (e.g., sodium bicarbonate) due to precipitation risk. Monitor for fluid overload in patients with CHF or renal impairment. Warming LR before infusion prevents hypothermia. |
| Patient Advice | This solution replaces fluids and electrolytes in your body. · Tell your doctor if you have kidney problems, heart failure, or liver disease. · Report any signs of fluid overload, such as swelling in ankles or shortness of breath. · Inform your healthcare provider of all medications you are taking, especially diuretics or potassium supplements. · You may experience a warm sensation at the IV site; inform staff if pain or redness occurs. |
Loading safety data…